Výsledky vyhledávání - "Sonalee Agarwal"

Akademický článek

Comparison of adherence and persistence among multiple sclerosis patients treated with disease-modifying therapies: a retrospective administrative claims analysis

Autor: Rachel Halpern, Sonalee Agarwal, Carole Dembek, et al

Publikováno v: Patient Preference and Adherence, Vol 2011, Iss default, Pp 73-84 (2011)

Rachel Halpern1, Sonalee Agarwal2, Carole Dembek2, Leigh Borton1, Maria Lopez-Bresnahan31Health Economics and Outcomes Research, i3 Innovus, Eden Prairie, MN, USA; 2Health Outcomes and Pharmacoeconomics, Biogen Idec, Wellesley, MA, USA; 3Medical and

Externí odkaz: https://doaj.org/article/6c9b2fcb86cd432bb693a0d285d983ec

Zobrazit plný text záznamu

Evaluating Prognostic Factors for Liver Transplantation Among United States Patients With Hereditary Transthyretin-Mediated (hATTR) Amyloidosis Using National Registry Data

Autor: Sonalee Agarwal, William Irish, Saša A. Živković, Danielle Brandman, Jared Gollob, Larry Gache, Hollis Lin, Anastasia McManus

Publikováno v: Progress in Transplantation. 29:213-219

Introduction: Orthotopic liver transplantation has been used as a treatment for hereditary transthyretin-mediated (hATTR) amyloidosis, a rare, progressive, and multisystem disease. Research Question: The objective is to evaluate survival outcomes pos

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eba9f69d7bbbc5e8ca9bda2ef69e54eb
https://doi.org/10.1177/1526924819853832

Zobrazit plný text záznamu

Patient Perspective on Acute Intermittent Porphyria with Frequent Attacks: A Disease with Intermittent and Chronic Manifestations

Autor: Jae B. Kim, William Querbes, Amy Simon, Patrick Marquis, Alex Wei, Sonalee Agarwal, Jessica R. Hungate, Desiree Lyon Howe, Farrah Pompilus, Sara Strzok, Craig Penz

Publikováno v: The Patient

Objective Acute intermittent porphyria is a rare metabolic disorder that affects heme synthesis. Patients with acute intermittent porphyria may experience acute debilitating neurovisceral attacks that require frequent hospitalizations and negatively

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17839a5936ac428b0716f47f2aa1515c
https://doi.org/10.1007/s40271-018-0319-3

Zobrazit plný text záznamu

Response to the letter to the editor on 'an indirect treatment comparison of the efficacy of patisiran and tafamidis for the treatment of hereditary transthyretin-mediated amyloidosis with polyneuropathy'

Autor: Hollis Lin, Marissa Blieden Betts, Kyle Fahrbach, Michael Polydefkis, Madhura Chitnis, Sonalee Agarwal

Publikováno v: Expert opinion on pharmacotherapy. 20(12)

We thank the authors of the recent letter to the editor [1] for their thoughtful review of our article, ‘An indirect treatment comparison of the efficacy of patisiran and tafamidis for the treatmen...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98baa083ca9019071eb24b26b8bf13ba
https://pubmed.ncbi.nlm.nih.gov/31124724

Zobrazit plný text záznamu

Patient Perspective on Hereditary Transthyretin-Mediated (hATTR) Amyloidosis: A Qualitative Review

Autor: Elizabeth A. Mauricio, William R. Lenderking, Shannon Shaffer, Jaclyn Franklin, Sonalee Agarwal, Cynthia Bither, Johana Fajardo

Publikováno v: Heart & Lung. 49:213

Background Hereditary transthyretin-mediated (hATTR) amyloidosis is a rare, inherited, rapidly progressive, life-threatening disease. It is caused by a mutation in the transthyretin (TTR) gene that results in misfolded TTR proteins that accumulate as

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fa629c5d07829142ed6f4d877406fe3c
https://doi.org/10.1016/j.hrtlng.2020.02.016

Zobrazit plný text záznamu

Alnylam Act®: Heterogenous Disease Manifestations of Hereditary Transthyretin-Mediated Amyloidosis

Autor: Tom Winder, Ruthvik Malladi, Quinn Dinh, Sonalee Agarwal, Maria Melanson, Rebecca Truty

Publikováno v: Journal of Cardiac Failure. 25:S111-S112

Hereditary transthyretin-mediated (hATTR) amyloidosis is an inherited, progressively debilitating, fatal disease caused by a mutation in the transthyretin (TTR) gene. hATTR amyloidosis results in abnormal amyloid accumulation in multiple sites causin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fac5689a0822f120949050d932d75825
https://doi.org/10.1016/j.cardfail.2019.07.318

Zobrazit plný text záznamu

Long-term natalizumab treatment is associated with sustained improvements in quality of life in patients with multiple sclerosis

Autor: Timothy Vollmer, Judith J. Stephenson, Sonalee Agarwal, John F. Foley, Crystal Watson, Kavita V. Nair, Timothy Niecko

Publikováno v: Patient preference and adherence

John F Foley,1 Kavita V Nair,2 Timothy Vollmer,3 Judith J Stephenson,4 Timothy Niecko,5 Sonalee S Agarwal,6 Crystal Watson6 1Rocky Mountain Multiple Sclerosis Clinic, Salt Lake City, UT, USA; 2Skaggs School of Pharmacy and Pharmaceutical Sciences, Un

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::911cc9a4140fe4bf75bb86ff53282620
https://pubmed.ncbi.nlm.nih.gov/28670113

Zobrazit plný text záznamu

Efficacy and safety of BG-12 (dimethyl fumarate) and other disease-modifying therapies for the treatment of relapsing–remitting multiple sclerosis: a systematic review and mixed treatment comparison

Autor: Robert J. Fox, Michael Hutchinson, Nuwan Kurukulasuriya, Ankush Taneja, M.K. Siddiqui, Sonalee Agarwal, Baris Deniz, Eva Havrdova, Sujata P. Sarda

Publikováno v: Current Medical Research and Opinion. 30:613-627

Currently, direct comparative evidence or head-to-head data between BG-12 (dimethyl fumarate) and other disease-modifying treatments (DMTs) is limited. This study is a systematic review and data synthesis of published randomized clinical trials compa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b49298b03c8af77db33a2a90ccd56b28
https://doi.org/10.1185/03007995.2013.863755

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání